Managed Print Services Marke Analysis To Reach $49.7 Billion By 2025

San Francisco, 25 September 2018 – According to a report by Grand View Research, Inc., global managed print services (MPS) market is anticipated to value USD 49.7 billion by 2025. Growing requirement to reduce wastage of paper to print documents and operational cost in organizations is anticipated to propel demand for managed print services. Such services can help reduce number of local printers, replace inefficient devices by analyzing printing needs, and remote printing operations. In addition, MPS can also track and manage complete document environment.

north-america-managed-print-services-market.png

Growing security concerns related to data and important information in organizations is expected to influence demand for managed print services. Growing adoption of advanced technologies such as cloud computing and analytics is anticipated to fuel growth of market. Government regulations to reduce paper wastage and save trees for better environmental conditions globally can stimulate market growth during the forecast period (2014 to 2025).

The managed print services market can be segregated on the basis of channel, deployment, organization, application, and region. Based on channel, the market can be categorized into system integrators, independent software vendors, and printers/copiers manufacturers. In 2016, printer manufacturer segment accounted for largest market share. Prevalence of printer/copier manufacturer, supportive government regulations, and increasing number of startups can stimulate market growth.

Browse Research Report Managed Print Services Marke :
www.grandviewresearch.com/industry-analysis/managed-print-services-mps-market

On the contrary, system integrators segment is likely to expand at CAGR of 7.1% during the forecast period. It’s a channel type that can market printer/copier manufacturer and other offers.

Based on deployment, the market can be classified into cloud-based, on premises, and hybrid. In 2016, cloud based deployment segment dominated the market and accounted for 40% of overall market. End-users are likely to benefit from cost-effective managed print services. These benefits can change aspects of IT model. Cloud based server can be installed easily on OEM server and accesses through web browser. It can be priced on monthly and annual basis with additional recurring fees for training and support.

In addition, hybrid deployment mode is predicted to grow at highest CAGR of 7.1% during the forecast period. It is likely to offer both on premise and cloud based deployment modes. Hence, few services are hosted locally (on premises) and other are hosted by cloud service providers.

Based on organization, the market can be bifurcated into large enterprises and small & medium enterprises. In recent years, large enterprises segment dominated the market. It is expected to bode well for MPS market and grow at phenomenal CAGR of 6.7% during the forecast period. Increasing cases of malware, spams, attack, threat, and other exposures in large enterprises can boost demand for MPS.

In addition, small and medium enterprises can also contribute well in market share during the forecast period. Competitive attractiveness from several market entrants and rising security concerns are anticipated to propel demand for MPS in small and medium enterprises.

Based on application, the market can be segmented into government, education, healthcare, BFSI, industrial manufacturing, retail & consumer goods, telecom & IT, and others. In 2016, Banking, Financial Services, and Insurance (BFSI) segment dominated the market and accounted for largest market share equivalent to USD 6718.5 million. BFSI sector is likely to involve files and lots of paperwork demanding privacy and security. MPS can help maintain required security and privacy of such documents.

Regional segmentation includes North America, Asia Pacific, Europe, South America, and Middle East & Africa. In 2016, Asia Pacific dominated the market and accounted for market share equivalent to USD 4011.8 million. Growing number of consumer goods and retail startups in countries such as India, China, and Japan can stimulate growth of market in the region. In addition, increasing adoption of managed print services in countries such as Singapore and Australia attributed to growing awareness in healthcare and education applications can fuel growth.

Similarly, North America is predicted to contribute well for market growth owing to increasing adoption of MPS in government and healthcare sector of United States (U.S.). In addition, launch of new programs and strategic acquisitions to create awareness of managed print services can augment market growth during the forecast period.

Some of the leading companies offering managed print services are Lexmark, Xerox Corporation, Hewlett-Packard, Canon, and Ricoh.

View more reports of this category by Grand View Research at
www.grandviewresearch.com/industry/emerging-and-next-generation-technologies

Grand View Research has segmented the managed print services market report on the basis channel, deployment, organization, application and region:

Managed Print Services Channel Outlook (Revenue, USD Million, 2014 – 2025)

  • Printers/Copiers Manufacturers
  • System Integrators
  • Independent Software Vendors

Managed Print Services Deployment Outlook (Revenue, USD Million, 2014 – 2025)

  • On Premises
  • Cloud based
  • Hybrid

Managed Print Services Organization Outlook (Revenue, USD Million, 2014 – 2025)

  • Small and Medium Enterprises
  • Large Enterprises

Managed Print Services Application Outlook (Revenue, USD Million, 2014 – 2025)

  • BFSI
  • Education
  • Government
  • Healthcare
  • Industrial Manufacturing
  • Retail & Consumer goods
  • Telecom & IT
  • Others

Regional Outlook (Revenue, USD Million, 2014 – 2025)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Browse Press Release of this Report:
www.grandviewresearch.com/press-release/global-managed-print-services-mps-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Advertisements

HIV Diagnostics Market Future To Reach $4.48 Billion By 2022 | Leading Players Janssen Therapeutics, Gilead Sciences

San Francisco, 25 September 2018 – Global HIV Diagnostics Market is expected to reach USD 4.48 billion by 2022, growing at an estimated CAGR of 9.5% from 2015 to 2022, according to a new study by Grand View Research, Inc. Key factors accounting for the growth of this market include the growing need in for the development of more sensitive HIV diagnostic point of care tests which can be easily implemented at the location of patient care in resource limited settings. Technological development of tests which is expected to introduce a number of novel rapid, point-of-care tests throughout the forecast period is a primary factor expected to fuel the growth of the HIV diagnostics market. Furthermore, government programs and campaigns initiated against HIV, global healthcare efforts to reduce disease incidence, and the presence of high unmet demand in the Middle Eastern and Eastern regions of the market are some key factors expected to serve as lucrative future growth opportunities.

                 Global HIV diagnostics market, By product, 2012 – 2022 (USD Million)

hiv-diagnostics-market

Browse Research Report On HIV Diagnostics Market :
www.grandviewresearch.com/industry-analysis/hiv-diagnostics-market

Further key findings from the study suggest:

  • Antibody HIV diagnostic tests accounted for the largest share of the market in 2014. This large share can be accounted for by the high market usage and penetration rates of these tests which include, ELISA, home access dried blood spot, western blot testing IFA and RIPA.  These tests are highly sensitive and accurate and thus are most commonly used for screening and confirmation of HIV-1 & HIV-2.
  • Viral Load testing and CD4 testing also accounted for a considerable share of the market in 2014. There is a prevalent in the market for the development of these tests which will make them more sensitive, rapid in nature and portable to the point of care to enhance their market usability and accessibility in resource limited HIV affected regions.
  • It is expected that during the forecast period a number of novel point of care HIV diagnostic products will be commercialized which are currently under clinical development and in product pipelines of key market players. This increase in the range of products s expected to fuel the growth of this market over the forecast period.
  • North America was observed to account for the largest share of the market in 2014, which can be attributed to the presence of a strong healthcare R&D scenario in which the presence of government funding and ongoing corporate efforts to enhance product portfolio are anticipated to accelerate the timelines for new product development. Furthermore, the presence of favorable reimbursements policies for HIV and other infectious diseases is also a factor accounting for this region’s large share.
  • Asia Pacific is expected to grow at a relatively faster rate over the forecast period owing to, the presence of high levels of unmet market demand for HIV screening and testing. Moreover, collaborations among market participants from the western regions is another significant expected to boost the growth of Asia Pacific HIV diagnostics market during the forecast period.
  • Key players of the market include Janssen Diagnostics, Daktari Diagnostics, Cepheid, Hologic and Chembio Diagnostic Systmes Inc.

View more reports of this category by Grand View Research at
www.grandviewresearch.com/industry/clinical-diagnostics

Grand View Research has segmented the HIV diagnostics market on the basis of product and region:

HIV Diagnostics Product Outlook (Revenue, USD Million, 2012 – 2022) 

  • Antibody Tests
    • HIV-1 Screening Tests
      • ELISA/EIA
      • Home Access Dried Blood Spot
      • Rapid Tests (Dot plot, Agglutination Tests)
    • HIV-1 Antibody Confirmatory Tests
      • Western Blot Test
      • Indirect Immunofluorescent Antibody Assay (IFA)
      • Line Immunoassay
      • RadioImmunoPrecipitation Assay (RIPA)
    • HIV-2 & Group O Diagnostic Tests
      • Blood Antibody Tests
      • Dried Blood Spot (DBS) Test
      • Others and (Oral, Urine)
    • Viral Identification Assays
      • P24 Antigen Test
      • Qualitative PCR Tests
      • Viral Culture
    • CD4 Testing
    • Viral Load Testing
    • Early Infant Diagnostics

HIV Diagnostics Regional Outlook (Revenue, USD Million, 2012 – 2022) 

  • North America
    • US
      • US HIV Diagnostics Market, by Product
    • Canada
      • Canada HIV Diagnostics Market, by Product
    • Europe
      • Germany
        • Germany HIV Diagnostics Market, by Product
      • UK
        • UK HIV Diagnostics Market, by Product
      • Asia Pacific
        • Japan
          • Japan HIV Diagnostics Market, by Product
        • China
          • China HIV Diagnostics Market, by Product
        • Latin America
          • Brazil
            • Brazil HIV Diagnostics Market, by Product
          • MEA
            • South Africa
              • South Africa HIV Diagnostics Market, by Product

Browse Press Release of this Report:
www.grandviewresearch.com/press-release/global-hiv-diagnostics-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Automotive Coolant Market Worth $1.23 Billion By 2024 | Key Industry Players Royal Dutch Shell, ExxonMobil Corporation

San Francisco, 25 September 2018 – The U.S. automotive coolant market is expected to reach USD 1.23 billion by 2024, according to a new report by Grand View Research, Inc. Increasing passenger car sales as a result of increased consumer confidence and high disposable income in recent years has impacted industry growth to a large extent.

The U.S. Department of Environmental Quality (DEQ) has decreed antifreeze recycling standards under the ‘Best Management Practices’ in the industry, leading to greater consumption of recycled coolants with low toxin content. Growing consumer awareness regarding recyclable & sustainable materials is further likely to impact industry growth positively over the forecast period.

U.S. Automotive Coolant Market Revenue By Product, 2014 – 2024 (USD Million)

us-automotive-coolant-market.png

Propylene glycol emerged as the leading product segment and accounted for over 55% of total demand in 2015 on account of its growing demand as a substitute for conventional ethylene glycol coolants. It is also expected to witness the highest growth over the forecast period. High growth of propylene glycol can be attributed to the product’s non-toxicity & greater freeze point depression properties.

Browse Research Report On Automotive Coolant Market :
www.grandviewresearch.com/industry-analysis/us-automotive-coolant-market

Further key findings from the study suggest:

  • The U.S. automotive coolant market demand was 61.7 million gallons in 2015 and is expected to reach 118.0 million gallons by 2024, growing at a CAGR of 7.9% from 2016 to 2024
  • High consumer awareness regarding the ethylene glycol based coolants advantageous characteristics such as convective heat transfer properties is expected to foster its application as an antifreeze & corrosion inhibitor in automobiles.
  • Coolants based on the organic acid technology (OAT) dominated the industry owing to their phosphate-free nature
  • OAT segment is anticipated to grow at a rapid pace owing to its ability to provide superior protection to the automotive cooling system, while maintaining compatibility with exotic materials such as aluminum & magnesium
  • The OEM distribution segment is anticipated to lose importance to the automotive aftermarket, since most automobile manufacturers refrain from assuming the responsibility of coolant refilling
  • Commercial vehicles segment is expected to be the dominant end-use segment with its growth projected at over 8% from 2016 to 2024
  • Increasing trade activities post revival of the U.S. economy has stimulated the demand for commercial heavy-duty vehicles leading to high coolant demand in the region
  • Major industry participants include Lukoil, Total S.A., KOST USA, Motul, Ashland Incorporation, British Petroleum PLC, Royal Dutch Shell, Exxon Mobil Corporation, Chevron Phillips Corporation, and Sinopec among several others.

View more reports of this category by Grand View Research at
www.grandviewresearch.com/industry/petrochemicals-and-downstream-derivatives

Grand View Research has segmented the U.S. automotive coolant market on the basis of product, technology, distribution and end-use:

U.S. Automotive Coolant Product Outlook (Volume, Million Gallons; Revenue, USD Million, 2014 – 2024)

  • Ethylene Glycol
  • Propylene Glycol
  • Glycerin

U.S. Automotive Coolant Technology Outlook (Volume, Million Gallons; Revenue, USD Million, 2014 – 2024)

  • Inorganic Acid Technology (IAT)
  • Organic Acid Technology (OAT)
  • Hybrid Organic Acid Technology (HOAT)

U.S. Automotive Coolant Distribution Outlook (Volume, Million Gallons; Revenue, USD Million, 2014 – 2024)

  • Original Equipment Manufacturers (OEM)
  • Automotive Aftermarket

U.S. Automotive Coolant End-Use Outlook (Volume, Million Gallons; Revenue, USD Million, 2014 – 2024)

  • Passenger Cars
  • Commercial Vehicles
  • Two-Wheelers

Browse Press Release of this Report:
www.grandviewresearch.com/press-release/us-automotive-coolant-market-analysis

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Nephrology & Urology Market Size To Reach $31.3 Billion By 2024 | Key Industry participants Fresenius Medical Care, C.R. Bard Inc.

San Francisco, 25 September 2018 – The global nephrology and urology devices market size is expected to reach USD 31.3 billion by 2024, according to a new report by Grand View Research, Inc., exhibiting a 7.1% CAGR during the forecast period. Increasing prevalence of chronic kidney diseases is expected to fuel market growth.

This high prevalence of diseases can be attributed to unhealthy lifestyle habits of people around the world. Moreover, growing geriatric population, who are more prone to hypertension, obesity, diabetes, urinary disorders, and other kidney chronic conditions, is expected to fuel demand for nephrology and urology devices.

us-nephrology-urology-devices-market

Advancements in device technology, such as inclusion of prosthetics in urology, percutaneous methods for stone disintegration and extraction, and extracorporeal shockwave lithotripsy, are anticipated to boost the market over the forecast period. Furthermore, presence of highly advanced pipeline products such as bioartificial kidney is presumed to present the market with lucrative growth opportunities in future.

Increase in demand for minimally invasive techniques is also likely to propel the market in the coming years. Nephrology and urology devices facilitate early diagnosis and shorter treatment duration in most surgical procedures. Minimal pain, heightened cost efficiency, safety, efficacy, rapid recovery, and reduced hospital stay are other benefits offered by these devices. This is expected to boost adoption over the forecast period.

Browse Research Report On Nephrology & Urology Market :
www.grandviewresearch.com/industry-analysis/nephrology-urology-devices-market

Further key findings from the report suggest:

  • The global urology segment is anticipated to reach USD 21.4 billion by 2024, at a CAGR of 6.9% from 2016 to 2024
  • By type, the benign prostatic hyperplasia segment is anticipated to witness lucrative growth over the forecast period
  • Europe held the dominant revenue share as of 2015 owing to a large target population. Growth across this region is primarily driven by presence of prominent market players implementing extensive expansion strategies such as product development and mergers and acquisitions
  • Asia Pacific, especially countries such as India and China, is expected to observe remarkable growth in the coming years
  • The global industry is dominated by few players and is marked by extensive new product development and high-end investments in R&D. Level of competition is expected to remain high over the forecast period
  • Some of the key players in the market are Baxter International, Inc.; Fresenius Medical Care AG & Co. KGaA; Boston Scientific; and C.R. Bard Inc.

View more reports of this category by Grand View Research at
www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the global nephrology and urology devices market on the basis of type and region:

Nephrology and Urology Devices Type Outlook (Revenue, USD Billion, 2013 – 2024)

  • Dialysis
  • Urinary Stone
    • Ureteral stents
    • Lithotripters
  • Urinary Incontinence & Pelvic Organ Prolapsed
    • Sacral neuromodulation
    • Vaginal meshes & slings
    • Ureteral inserts & pessaries
  • Benign Prostatic Hyperplasia
    • Catheter ablation
    • Prostatic stents
  • Endoscopy
  • Others

Nephrology and Urology Devices Regional Outlook (Revenue, USD Billion, 2013 – 2024)

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • Japan
    • China
    • India
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • South Africa

Browse Press Release of this Report:
www.grandviewresearch.com/press-release/global-nephrology-urology-devices-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Nebulizer Market Opportunities To Reach $1.3 Billion By 2025

San Francisco, 25 September 2018 – According to a report by Grand View Research, Inc., global nebulizer market is anticipated to value USD 1.3 billion by 2025. Growing requirement for healthcare devices that can be used at home by geriatric population is anticipated to propel demand for nebulizers. Compact design of nebulizers make it easy for patients suffering from respiratory issues to use such devices being at home. Nebulizer is an advanced drug delivery device that can be used to administer medication in the form of mist inhaled into lungs.

north-america-nebulizer-market.png

Rising cases of respiratory disorders coupled with increasing number of geriatric population can fuel growth of market. Elderly people are susceptible to chronic diseases such as sleep apnea and chronic obstructive pulmonary disease (COPD). This, in turn, is expected to increase patients demanding home healthcare devices, which can come cost-effective as compared to hospital stays. Growing adoption of compact and technologically advanced medical devices at home can stimulate market growth in the forthcoming years. Reduced drug loss and incorporation of advanced technologies are expected to augment demand for portable nebulizers. High demand to curb healthcare expenditure is likely to surge demand for home healthcare devices such as nebulizers. Continual R&D activities to reduce sound created by medical devices and increase compactness is expected to augment market growth during the forecast period (2014 to 2025).

Browse Research Report On Nebulizer Market :
www.grandviewresearch.com/industry-analysis/nebulizers-market

To cater to rising demand for portable medical devices, most companies are focusing on R&D activities to develop technologically advanced and compact nebulizers. For instance, Omron recently launched its new nebulizer for infants named DuoBaby nebulizer. The device is expected to be 2-in-1 compressor nebulizer integrated with nasal aspirator to help treat common respiratory problems in babies. It can efficiently deliver medication to upper and lower airways while aspirator can gently clean baby’s nose to avoid any congestion. In addition, nasal aspirator can also be used to remove mucus from baby’s nose through suction based on venture effect. Removed mucus is likely to get collected inside collection chamber, which can be cleaned easily. Moreover, device package is expected to contain two additional inhalation tops for nebulizer kit. These exchangeable tops can be used to treat airways conditions such as bronchitis, bronchiolitis, and asthma related to lower airways along with lower airways conditions such as cold, allergies, and blocked nose.

The nebulizer market can be segregated on the basis of product and region. Based on product, the market can be categorized into ultrasonic, mesh, and pneumatic. In 2016, pneumatic segment dominated the market and accounted for largest market share. High prevalence of respiratory disorders among geriatric population can contribute well for product demand. In addition, rising level of environmental pollution coupled with increasing number of smokers is likely to stimulate growth of market during the forecast period.

Similarly, mesh segment is estimated to display substantial growth during the forecast period. Continual technological advancements in nebulizers to increase their efficiency and efficacy can boost market growth in the forthcoming years. Nebulizers with vibrating mesh are likely to generate therapeutic aerosols with high efficiency, fine particle fractions, low residual volumes, and capability of nebulizing microliter volumes.

Regional segmentation includes Europe, North America, Asia Pacific, Latin America, and Middle East & Africa. In 2016, North America dominated the market and contributed for maximum market share. Growing number of geriatric population liable to respiratory disorders and surgeries is anticipated to propel demand for nebulizers in the region. Favorable initiatives from local governments to reduce patient’s stay in hospital attributed to cost containment issues in related to healthcare can boost market growth in the region.

In Asia Pacific, the market is expected to witness significant growth during the forecast period. According to Japan’s ministry of health, COPD is expected to be the seventh most common cause of death in the country. Rapidly increasing cases of COPD in Japan is likely to fuel demand for nebulizers. In addition, rising cases of pulmonary diseases in countries such as India and China can further influence demand for such devices in the region.

Some of the leading companies offering nebulizers are Omron Corporation, Dickinson and Company, Agilent Technologies, Briggs Healthcare, and Becton Dickinson.

View more reports of this category by Grand View Research at
www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the global nebulizer market report on the basis of product, and region:

Nebulizer Product Outlook Revenue (USD Million, 2014 – 2025)

  • Pneumatic
  • Ultrasonic
  • Mesh

Nebulizer Product Outlook Volume (Units, 2014 – 2025)

  • Pneumatic
  • Ultrasonic
  • Mesh

Regional Outlook (Revenue, USD Million, 2014 – 2025)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Browse Press Release of this Report:
www.grandviewresearch.com/press-release/global-nebulizers-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Oxygen Conservation Devices-Systems Market Analysis To Reach $2.21 Billion By 2025

San Francisco, 24 September 2018 – According to a report published by Grand View Research, Inc.; the oxygen conservation devices (OCD)/ systems market is likely to reach a valuation of around USD 2.21 billion by 2025.

Growing rate of chronic respiratory diseases is expected to boost the demand for OCD during the forecast period (2014 to 2025). In addition, supportive regulatory framework and improvements in reimbursement policies are also expected to increase the product demand.

us-oxygen-conservation-devices-market

High prevalence of Chronic obstructive pulmonary disease (COPD) and other respiratory ailments is likely to increase the demand for oxygen therapy and these products, according to WHO. Additionally, factors such as changing lifestyle and rise in indoor and outdoor pollution are responsible for asthma. As per statistics provided by Global Asthma Network, approximately 334 million individual gets affected with asthma globally. This indicates the potential need for these devices.  Increasing demand for technologically advanced products which may offer better portability, less oxygen wastage, and improved patient response are expected to create lucrative opportunities in the market.

Worldwide oxygen conservation devices/ systems market can be divided into product, end-use, and region. Based on product, the market can be bifurcated into reservoir oxygen delivery devices, electromechanical pulsing devices, transtracheal catheters, and others.

Electromechanical pulsing devices segment is expected to grow at a lucrative rate of 12.5% due to their better oxygen conserving efficiency as compared to other products.

Browse Research Report On Oxygen Conservation Devices-Systems Market
www.grandviewresearch.com/industry-analysis/oxygen-conservation-devices-systems-market

In 2016, reservoir oxygen delivery devices segment accounted for major market share due to its early introduction. These devices are also known as reservoir cannulas and recommended for patients requiring higher flow. The transtracheal catheters segment is expected to show moderate growth over the forecast period. These products are similarly efficient as that of reservoir oxygen delivery systems. These devices are recommended for patients suffering from obstructive and restrictive lung diseases.

As per end-use, the market can be classified into hospitals and clinics, long-term care units, and home care. In 2016, home care segment captured the largest share due to growing implementation of long- term oxygen therapy devices in home care settings. Long-term care units segment is likely to show profitable gains during the study period due to growing adoption of these unit in developed countries.

Geographically, the market can be divided into North America, Europe, Asia Pacific, Latin America, and The Middle East and Africa.

In 2016, North America accounted for the largest market share due to growing expenditure for R&D and trials related to O2 therapy, presence of major market players, established reimbursement framework, and growing occurrence of chronic respiratory diseases. Growing number of FDA approvals to implementation of oxygen therapy in applications including diabetes, cancer, and autism are likely to boost the market in the region. Besides, rising efforts to promote awareness regarding oxygen therapy by the organizations including Canadian Thoracic Society and Canadian Society of Respiratory Therapy is also supporting the market growth in the region.

Asia Pacific is expected to grow with lucrative rate at 13.6% over the forecast period due to growing healthcare sector and rise in elderly population that will require home-based oxygen therapy. Factors such as existence of high untapped opportunities, increasing disposable income, rising government expenditure for healthcare, and continues R&D efforts to develop novel products can boost the market in the region. In addition, development of nongovernment organizations like Asthma and Clinical Immunology and the Asia Pacific Association of Allergy are likely to increase awareness regarding the treatment of respiratory disorders. This is anticipated to increase adoption of these devices in the region.

Prominent players operating in the market include Responsive Respiratory, Inc.; Medline Industries, Inc.; Precision Medical, Inc.; Essex Industries, Inc.; and Medical Depot, Inc.

Market participants are mainly focused on development of new product, collaborations, and mergers and acquisitions to improve their presence in the market. The competition among the players will be based on frequent product approvals, growing number of participants, efficient distribution agreement, and devolvement of better product that may reduce the wastage of     gas.

View more reports of this category by Grand View Research at
www.grandviewresearch.com/industry/medical-devices

 Product Outlook (Revenue, USD Million, 2014 – 2025)

  • Nanoparticles
    • Liposomes
    • Polymers
    • Micelles
    • Other nanoparticles
  • Embolization particles
    • PVA particles
    • Drug eluting beads
    • Liquid emboli
    • Other embolization particles

Regional Outlook (Revenue, USD Million, 2014 – 2025)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Browse Press Release of this Report:
www.grandviewresearch.com/press-release/global-oxygen-conservation-devices-systems-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Idiopathic Thrombocytopenic Purpura Therapeutics Market Future To Reach $566.4 Million By 2022 | Leading Players Grifols Biologicals Inc., GlaxoSmithKline Plc.

San Francisco, 24 September 2018 – Global idiopathic thrombocytopenic purpura (ITP) therapeutics market is expected to reach USD 566.4 million by 2020. Rising R&D leading to the introduction of new drugs for IVIG and TPO-RA classes is expected to propel growth over the forecast period. In addition, government regulation such as the Orphan Drug Act in the United States with an aim to encourage new product development is projected to fuel growth.

The industry is characterized by rising demand for combination therapies as they exhibit higher efficiency as compared to other treatments. Moreover, they are cost efficient and help curb side effects associated with individual therapeutic classes. Some of the major combination therapies are dexamethasone and rituximab, dexamethasone and TPO-RA, IVIG and corticosteroids. Splenectomy, the procedure to remove spleen is aimed at reducing the amount of anti-platelet antibodies, is expected to fuel demand.

Global ITP therapeutics market, by product, 2012 – 2020 (USD Million)

idiopathic-thrombocytopenic-purpura-itp-therapeutics

The global market for corticosteroid is valued at over USD 125.0 million in 2013. Corticosteroids are regularly used in idiopathic thrombocytopenic purpura treatment. Since corticosteroid are considered to be the first line of therapy for patients suffering from ITP, the usage rates of corticosteroid are very high.

Browse Research Report On Idiopathic Thrombocytopenic Purpura Therapeutics Market :
www.grandviewresearch.com/industry-analysis/idiopathic-thrombocytopenic-purpura-itp-therapeutics

TPO-RA is likely to witness substantial growth, growing at a CAGR of over 9.0% from 2014 to 2020 owing to high response rates exhibited by patients administered with Eltrombopag and Romiplostim. Moreover, demand for TPO-RA is expected to increase due to the commercialization of Avatrombopag in 2015. In addition, the ability of TPO-RA to cater to splenectomized patients witnessing relapses is expected fuel demand over the next six years.

North America accounted for a majority share in 2013 due to rising occurrence of diseases coupled with the presence of high treatment rates, favorable government initiatives, and funding programs. North America had a share of over 40% of the global ITP market by revenue in 2013 and is expected to witness high demand over the forecast period.

Europe accounted for the second largest market share in 2013. This trend is projected to continue over the forecast period due to high usage rates of products along with government initiatives granting of special status to orphan drugs factors.

Asia Pacific is expected to experience substantial growth over the next six years, owing to the presence of favorable government initiatives, and sophisticated healthcare infrastructure in Australia and Japan. In addition, the presence of vast untapped opportunities in emerging markets such as China and India is expected to propel growth.

Some of the major players in the industry are and GlaxoSmithKline Plc., Hoffman-L Roche, Amgen Inc and Grifols Biologicals Inc. The companies make significant R&D investments aimed at new product development by taking advantage of incentives offered under the pertinent government regulations.

View more reports of this category by Grand View Research at
www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the global ITP therapeutics market on the basis of product and region:

Global ITP Therapeutics Product Outlook (Revenue, USD Million, 2012 – 2020)

  • Corticosteroids
  • Intravenous Immunoglobulin (IVIG)
  • Anti-D Immunoglobulin
  • Thrombopoietin Receptor Agonists (TPO-RA)
  • Others

ITP Therapeutics Regional Outlook (Revenue, USD Million, 2012 – 2020)

  • North America
    • US.
    • Mexico
  • Europe
    • Germany
    • UK
  • Asia Pacific
    • India
    • Japan
    • China
  • RoW
    • Brazil

Browse Press Release of this Report:
www.grandviewresearch.com/press-release/global-nitrile-butadiene-rubber-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com